This is reflective of the SLICC criteria published in 2013, which stated that combination of biopsy confirmed nephritis in the presence of either ANA or anti-dsDNA antibodies is sufficient for classification of SLE in humans (45). The gene discussed is BTG3; the disease is nephritis.